Patent · US Active

Diaminopyrimidines as P2X3 and P2X2/3 modulators

US7799796B2 · kind B2 · utility

5Cited by

42References

7Claims

0Family size

Assignee

Roche Palo Alto LLC · US

Inventors

Michael Patrick Dillon · Mill Valley, US
Alam Jahangir · San Jose, US
Clara Jeou Jen Lin · Palo Alto, US

Key dates

Filing date	Aug 25, 2006
Grant date	Sep 21, 2010
Priority date	—
Expiry date	Feb 28, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the compounds being of formula (I):wherein D, X, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.